Mirum Pharmaceuticals, Inc. · NASDAQ:MIRM
Bjerkholt Eric sold 5,000 Mirum Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 8 to Jun 9, 2026 · Filed Jun 9, 2026
From Jun 8 to Jun 9, 2026, Bjerkholt Eric (CHIEF FINANCIAL OFFICER) sold 5,000 Mirum Pharmaceuticals, Inc. shares at an average US$93.82 for US$469K under a trading plan, leaving 47,181 shares. Filed Jun 9, 2026 (Form 4).
- Sold
- 5,000 shares
- Price
- US$93.82 average (US$92.84 to US$95.12)
- Value
- US$469K
- Holding after
- 47,181 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CHIEF FINANCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Common Stock | Sale | 2,258 | US$92.84 | 47,530 | Direct |
| Jun 8, 2026 | Common Stock | Sale | 1,175 | US$93.95 | 46,355 | Direct |
| Jun 8, 2026 | Common Stock | Sale | 1,567 | US$95.12 | 44,788 | Direct |
| Jun 9, 2026 | Common Stock | Option exercise | 2,393 | US$26.49 | 47,181 | Direct |
Source
Related
- Mirum Pharmaceuticals, Inc.
- Bjerkholt Eric
- Mirum Pharmaceuticals, Inc. shareholders
- Form 4 · Bjerkholt Eric · Sep 15, 2026
- Form 4 · Bjerkholt Eric · Aug 12, 2026
- Form 4 · Bjerkholt Eric · Jul 8, 2026
- Form 4 · Howe Jolanda · Oct 19, 2026
- Form 4 · Peetz Christopher · Oct 6, 2026
- Form 4 · Howe Jolanda · Sep 3, 2026
- Form 4 · Peetz Christopher · Sep 3, 2026
- Form 4 · Howe Jolanda · Aug 19, 2026